More recently, bladder cancer cell lines with FGFR3 somatic mutation, FGFR3-TACC3 and FGFR3-BAI1AP2L1 gene fusions were all found to be sensitive to Hsp90 inhibition. The gene discussed is TACC3; the disease is urinary bladder carcinoma.